$AERI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AERIE PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AERIE PHARMACEUTICALS INC. Get notifications about new insider transactions in AERIE PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 17 2019 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Grant | A | 0.00 | 13,559 | 0 | 72,194 | 58.6 K to 72.2 K (+23.12 %) |
May 17 2019 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Payment of Exercise | F | 40.54 | 2,322 | 94,134 | 334,406 | 336.7 K to 334.4 K (-0.69 %) |
May 17 2019 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Grant | A | 0.00 | 13,559 | 0 | 336,728 | 323.2 K to 336.7 K (+4.20 %) |
May 17 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 40.54 | 4,145 | 168,038 | 171,381 | 175.5 K to 171.4 K (-2.36 %) |
May 17 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 32,171 | 0 | 175,526 | 143.4 K to 175.5 K (+22.44 %) |
Apr 15 2019 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Payment of Exercise | F | 41.89 | 1,549 | 64,888 | 323,169 | 324.7 K to 323.2 K (-0.48 %) |
Apr 15 2019 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Payment of Exercise | F | 41.89 | 1,564 | 65,516 | 58,635 | 60.2 K to 58.6 K (-2.60 %) |
Apr 15 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 41.89 | 2,612 | 109,417 | 143,355 | 146 K to 143.4 K (-1.79 %) |
Feb 20 2019 | AERI | AERIE PHARMACEUTIC ... | LaRocca John | General Counsel | Payment of Exercise | F | 40.80 | 1,542 | 62,914 | 23,458 | 25 K to 23.5 K (-6.17 %) |
Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | LaRocca John | General Counsel | Option Exercise | A | 43.07 | 31,000 | 1,335,170 | 31,000 | |
Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | LaRocca John | General Counsel | Grant | A | 0.00 | 7,000 | 0 | 25,000 | 18 K to 25 K (+38.89 %) |
Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Option Exercise | A | 43.07 | 36,000 | 1,550,520 | 36,000 | |
Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Payment of Exercise | F | 40.39 | 701 | 28,313 | 103,042 | 103.7 K to 103 K (-0.68 %) |
Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Grant | A | 0.00 | 8,000 | 0 | 103,743 | 95.7 K to 103.7 K (+8.36 %) |
Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 43.07 | 114,358 | 4,925,399 | 114,358 | |
Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 40.39 | 1,624 | 65,593 | 150,109 | 151.7 K to 150.1 K (-1.07 %) |
Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 25,413 | 0 | 151,733 | 126.3 K to 151.7 K (+20.12 %) |
Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Option Exercise | A | 43.07 | 57,500 | 2,476,525 | 57,500 | |
Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Payment of Exercise | F | 40.39 | 1,241 | 50,124 | 63,016 | 64.3 K to 63 K (-1.93 %) |
Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Grant | A | 0.00 | 12,778 | 0 | 64,257 | 51.5 K to 64.3 K (+24.82 %) |
Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Option Exercise | A | 43.07 | 48,000 | 2,067,360 | 48,000 | |
Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Payment of Exercise | F | 40.39 | 1,036 | 41,844 | 326,762 | 327.8 K to 326.8 K (-0.32 %) |
Feb 11 2019 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Grant | A | 0.00 | 10,667 | 0 | 327,798 | 317.1 K to 327.8 K (+3.36 %) |
Feb 01 2019 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 47.02 | 1,500 | 70,530 | 95,743 | 97.2 K to 95.7 K (-1.54 %) |
Feb 01 2019 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 46.03 | 9,500 | 437,314 | 97,243 | 106.7 K to 97.2 K (-8.90 %) |
Jan 02 2019 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 35.21 | 11,000 | 387,313 | 106,743 | 117.7 K to 106.7 K (-9.34 %) |
Dec 04 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 40.55 | 299 | 12,123 | 117,743 | 118 K to 117.7 K (-0.25 %) |
Dec 04 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 39.79 | 10,701 | 425,770 | 118,042 | 128.7 K to 118 K (-8.31 %) |
Nov 19 2018 | AERI | AERIE PHARMACEUTIC ... | Cagle Gerald D. | Director | Buy | P | 41.75 | 2,000 | 83,493 | 19,800 | 17.8 K to 19.8 K (+11.24 %) |
Nov 02 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Option Exercise | M | 0.40 | 3,251 | 1,284 | 0 | |
Nov 02 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 54.22 | 7,792 | 422,517 | 128,743 | 136.5 K to 128.7 K (-5.71 %) |
Nov 02 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 52.99 | 3,208 | 170,003 | 136,535 | 139.7 K to 136.5 K (-2.30 %) |
Nov 02 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Payment of Exercise | F | 52.55 | 25 | 1,314 | 139,743 | 139.8 K to 139.7 K (-0.02 %) |
Nov 02 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Buy | M | 0.40 | 3,251 | 1,284 | 139,768 | 136.5 K to 139.8 K (+2.38 %) |
Oct 01 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 61.34 | 1,670 | 102,435 | 136,517 | 138.2 K to 136.5 K (-1.21 %) |
Oct 01 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 60.43 | 9,330 | 563,769 | 138,187 | 147.5 K to 138.2 K (-6.32 %) |
Sep 28 2018 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Sell | S | 61.01 | 108 | 6,589 | 317,131 | 317.2 K to 317.1 K (-0.03 %) |
Sep 28 2018 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Sell | S | 60.36 | 16,497 | 995,797 | 317,239 | 333.7 K to 317.2 K (-4.94 %) |
Sep 28 2018 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Sell | S | 61.01 | 500 | 30,505 | 333,736 | 334.2 K to 333.7 K (-0.15 %) |
Sep 28 2018 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Sell | S | 60.18 | 49,500 | 2,978,940 | 334,236 | 383.7 K to 334.2 K (-12.90 %) |
Sep 18 2018 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Sell | S | 60.00 | 2 | 120 | 383,736 | 383.7 K to 383.7 K (0.00 %) |
Sep 14 2018 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Sell | S | 60.17 | 34,512 | 2,076,608 | 383,738 | 418.3 K to 383.7 K (-8.25 %) |
Sep 12 2018 | AERI | AERIE PHARMACEUTIC ... | GRYSKA DAVID W | Director | Option Exercise | A | 58.35 | 25,000 | 1,458,750 | 25,000 | |
Sep 06 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 61.00 | 1,000 | 61,000 | 147,517 | 148.5 K to 147.5 K (-0.67 %) |
Sep 06 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 60.00 | 10,000 | 600,024 | 148,517 | 158.5 K to 148.5 K (-6.31 %) |
Aug 29 2018 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Option Exercise | M | 3.15 | 7,332 | 23,096 | 63,498 | |
Aug 29 2018 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Option Exercise | M | 3.15 | 182,668 | 575,404 | 126,984 | |
Aug 29 2018 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Sell | S | 61.01 | 451 | 27,513 | 51,479 | 51.9 K to 51.5 K (-0.87 %) |
Aug 29 2018 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Sell | S | 60.27 | 189,549 | 11,423,493 | 51,930 | 241.5 K to 51.9 K (-78.50 %) |
Aug 29 2018 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Buy | M | 3.15 | 7,332 | 23,096 | 241,479 | 234.1 K to 241.5 K (+3.13 %) |
Aug 29 2018 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Buy | M | 3.15 | 182,668 | 575,404 | 234,147 | 51.5 K to 234.1 K (+354.84 %) |
Aug 02 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 68.69 | 4,790 | 329,003 | 158,517 | 163.3 K to 158.5 K (-2.93 %) |
Aug 02 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 68.00 | 6,210 | 422,295 | 163,307 | 169.5 K to 163.3 K (-3.66 %) |
Jul 05 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 67.09 | 2,600 | 174,440 | 169,517 | 172.1 K to 169.5 K (-1.51 %) |
Jul 05 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 66.15 | 8,400 | 555,624 | 172,117 | 180.5 K to 172.1 K (-4.65 %) |
Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 3.15 | 50,000 | 157,500 | 846,329 | |
Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 62.92 | 4,996 | 314,350 | 126,320 | 131.3 K to 126.3 K (-3.80 %) |
Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 61.90 | 45,004 | 2,785,946 | 131,316 | 176.3 K to 131.3 K (-25.52 %) |
Jun 13 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 3.15 | 50,000 | 157,500 | 176,320 | 126.3 K to 176.3 K (+39.58 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Option Exercise | A | 65.15 | 7,800 | 508,170 | 7,800 | |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Grant | A | 0.00 | 1,750 | 0 | 4,600 | 2.9 K to 4.6 K (+61.40 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 59.21 | 3,000 | 177,641 | 180,517 | 183.5 K to 180.5 K (-1.63 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 58.57 | 8,000 | 468,595 | 183,517 | 191.5 K to 183.5 K (-4.18 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 3.15 | 26,139 | 82,338 | 896,329 | |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 2.90 | 23,861 | 69,197 | 0 | |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 2.90 | 50,000 | 145,000 | 23,861 | |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | M | 2.90 | 50,000 | 145,000 | 73,861 | |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 64.52 | 29,717 | 1,917,362 | 126,320 | 156 K to 126.3 K (-19.04 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 63.35 | 20,283 | 1,284,924 | 156,037 | 176.3 K to 156 K (-11.50 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 3.15 | 26,139 | 82,338 | 176,320 | 150.2 K to 176.3 K (+17.40 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 2.90 | 23,861 | 69,197 | 150,181 | 126.3 K to 150.2 K (+18.89 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 62.80 | 16,386 | 1,029,092 | 126,320 | 142.7 K to 126.3 K (-11.48 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 62.06 | 33,614 | 2,085,957 | 142,706 | 176.3 K to 142.7 K (-19.06 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 2.90 | 50,000 | 145,000 | 176,320 | 126.3 K to 176.3 K (+39.58 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 61.10 | 4,338 | 265,044 | 126,320 | 130.7 K to 126.3 K (-3.32 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Sell | S | 60.44 | 45,662 | 2,760,003 | 130,658 | 176.3 K to 130.7 K (-25.90 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Buy | M | 2.90 | 50,000 | 145,000 | 176,320 | 126.3 K to 176.3 K (+39.58 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | MCGRAW BENJAMIN F III | Director | Option Exercise | A | 65.15 | 7,800 | 508,170 | 7,800 | |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | MCGRAW BENJAMIN F III | Director | Grant | A | 0.00 | 1,750 | 0 | 6,300 | 4.6 K to 6.3 K (+38.46 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | GOLDBERG MURRAY A | Director | Option Exercise | A | 65.15 | 7,800 | 508,170 | 7,800 | |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | GOLDBERG MURRAY A | Director | Grant | A | 0.00 | 1,750 | 0 | 6,300 | 4.6 K to 6.3 K (+38.46 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | du Toit Michael | Director | Option Exercise | A | 65.15 | 7,800 | 508,170 | 7,800 | |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | du Toit Michael | Director | Grant | A | 0.00 | 1,750 | 0 | 4,600 | 2.9 K to 4.6 K (+61.40 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | Croarkin Richard | Director | Option Exercise | A | 65.15 | 7,800 | 508,170 | 7,800 | |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | Croarkin Richard | Director | Grant | A | 0.00 | 1,750 | 0 | 4,600 | 2.9 K to 4.6 K (+61.40 %) |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | Cagle Gerald D. | Director | Option Exercise | A | 65.15 | 7,800 | 508,170 | 7,800 | |
Jun 08 2018 | AERI | AERIE PHARMACEUTIC ... | Cagle Gerald D. | Director | Grant | A | 0.00 | 1,750 | 0 | 17,800 | 16.1 K to 17.8 K (+10.90 %) |
May 29 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Option Exercise | M | 5.00 | 3,000 | 15,000 | 0 | |
May 29 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Sell | S | 50.15 | 2,708 | 135,806 | 191,517 | 194.2 K to 191.5 K (-1.39 %) |
May 29 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Payment of Exercise | F | 50.41 | 292 | 14,720 | 194,225 | 194.5 K to 194.2 K (-0.15 %) |
May 29 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Buy | M | 5.00 | 3,000 | 15,000 | 194,517 | 191.5 K to 194.5 K (+1.57 %) |
May 25 2018 | AERI | AERIE PHARMACEUTIC ... | Cagle Gerald D. | Director | Buy | P | 49.45 | 1,000 | 49,450 | 16,050 | 15.1 K to 16.1 K (+6.64 %) |
May 22 2018 | AERI | AERIE PHARMACEUTIC ... | Cagle Gerald D. | Director | Buy | P | 50.25 | 1,000 | 50,245 | 15,050 | 14.1 K to 15.1 K (+7.12 %) |
May 10 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Payment of Exercise | F | 53.85 | 539 | 29,025 | 191,517 | 192.1 K to 191.5 K (-0.28 %) |
May 10 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Payment of Exercise | F | 53.85 | 674 | 36,295 | 192,056 | 192.7 K to 192.1 K (-0.35 %) |
May 10 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Payment of Exercise | F | 53.85 | 331 | 17,824 | 192,730 | 193.1 K to 192.7 K (-0.17 %) |
May 10 2018 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Payment of Exercise | F | 53.85 | 776 | 41,788 | 418,250 | 419 K to 418.3 K (-0.19 %) |
May 10 2018 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Payment of Exercise | F | 53.85 | 857 | 46,149 | 419,026 | 419.9 K to 419 K (-0.20 %) |
May 10 2018 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Payment of Exercise | F | 53.85 | 410 | 22,079 | 419,883 | 420.3 K to 419.9 K (-0.10 %) |
May 10 2018 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Payment of Exercise | F | 53.85 | 1,027 | 55,304 | 51,479 | 52.5 K to 51.5 K (-1.96 %) |
May 10 2018 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Payment of Exercise | F | 53.85 | 1,027 | 55,304 | 52,506 | 53.5 K to 52.5 K (-1.92 %) |
May 10 2018 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Payment of Exercise | F | 53.85 | 763 | 41,088 | 53,533 | 54.3 K to 53.5 K (-1.41 %) |
May 10 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 53.85 | 1,351 | 72,751 | 126,320 | 127.7 K to 126.3 K (-1.06 %) |
May 10 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 53.85 | 2,054 | 110,608 | 127,671 | 129.7 K to 127.7 K (-1.58 %) |
May 10 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 53.85 | 1,052 | 56,650 | 129,725 | 130.8 K to 129.7 K (-0.80 %) |
Apr 16 2018 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Payment of Exercise | F | 53.40 | 1,564 | 83,518 | 54,296 | 55.9 K to 54.3 K (-2.80 %) |
Apr 16 2018 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Grant | A | 0.00 | 9,040 | 0 | 55,860 | 46.8 K to 55.9 K (+19.31 %) |
Apr 16 2018 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Payment of Exercise | F | 53.40 | 1,549 | 82,717 | 420,293 | 421.8 K to 420.3 K (-0.37 %) |
Apr 16 2018 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Grant | A | 0.00 | 9,040 | 0 | 421,842 | 412.8 K to 421.8 K (+2.19 %) |
Apr 16 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Payment of Exercise | F | 53.40 | 3,149 | 168,157 | 130,777 | 133.9 K to 130.8 K (-2.35 %) |
Apr 16 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 21,448 | 0 | 133,926 | 112.5 K to 133.9 K (+19.07 %) |
Feb 21 2018 | AERI | AERIE PHARMACEUTIC ... | LaRocca John | General Counsel | Option Exercise | A | 54.90 | 70,000 | 3,843,000 | 70,000 | |
Feb 21 2018 | AERI | AERIE PHARMACEUTIC ... | LaRocca John | General Counsel | Grant | A | 0.00 | 18,000 | 0 | 18,000 | 0 to 18 K |
Feb 12 2018 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Option Exercise | A | 53.55 | 48,000 | 2,570,400 | 48,000 | |
Feb 12 2018 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Grant | A | 0.00 | 10,667 | 0 | 412,802 | 402.1 K to 412.8 K (+2.65 %) |
Feb 12 2018 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Option Exercise | A | 53.55 | 57,500 | 3,079,125 | 57,500 | |
Feb 12 2018 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Grant | A | 0.00 | 12,778 | 0 | 46,820 | 34 K to 46.8 K (+37.54 %) |
Feb 12 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Option Exercise | A | 53.55 | 36,000 | 1,927,800 | 36,000 | |
Feb 12 2018 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Grant | A | 0.00 | 8,000 | 0 | 193,061 | 185.1 K to 193.1 K (+4.32 %) |
Feb 12 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Option Exercise | A | 53.55 | 114,358 | 6,123,871 | 114,358 | |
Feb 12 2018 | AERI | AERIE PHARMACEUTIC ... | ANIDO VICENTE JR | Chief Executive Off ... | Grant | A | 0.00 | 25,413 | 0 | 112,478 | 87.1 K to 112.5 K (+29.19 %) |
Jun 09 2017 | AERI | AERIE PHARMACEUTIC ... | Croarkin Richard | Director | Option Exercise | A | 52.85 | 10,000 | 528,500 | 10,000 | |
Jun 09 2017 | AERI | AERIE PHARMACEUTIC ... | Croarkin Richard | Director | Grant | A | 0.00 | 1,150 | 0 | 2,850 | 1.7 K to 2.9 K (+67.65 %) |
Jun 09 2017 | AERI | AERIE PHARMACEUTIC ... | Cagle Gerald D. | Director | Option Exercise | A | 52.85 | 10,000 | 528,500 | 10,000 | |
Jun 09 2017 | AERI | AERIE PHARMACEUTIC ... | Cagle Gerald D. | Director | Grant | A | 0.00 | 1,150 | 0 | 14,050 | 12.9 K to 14.1 K (+8.91 %) |
Jun 09 2017 | AERI | AERIE PHARMACEUTIC ... | du Toit Michael | Director | Option Exercise | A | 52.85 | 10,000 | 528,500 | 10,000 | |
Jun 09 2017 | AERI | AERIE PHARMACEUTIC ... | du Toit Michael | Director | Grant | A | 0.00 | 1,150 | 0 | 2,850 | 1.7 K to 2.9 K (+67.65 %) |
Jun 09 2017 | AERI | AERIE PHARMACEUTIC ... | GOLDBERG MURRAY A | Director | Option Exercise | A | 52.85 | 10,000 | 528,500 | 10,000 | |
Jun 09 2017 | AERI | AERIE PHARMACEUTIC ... | GOLDBERG MURRAY A | Director | Grant | A | 0.00 | 1,150 | 0 | 4,550 | 3.4 K to 4.6 K (+33.82 %) |
Jun 09 2017 | AERI | AERIE PHARMACEUTIC ... | MCGRAW BENJAMIN F III | Director | Option Exercise | A | 52.85 | 10,000 | 528,500 | 10,000 | |
Jun 09 2017 | AERI | AERIE PHARMACEUTIC ... | MCGRAW BENJAMIN F III | Director | Grant | A | 0.00 | 1,150 | 0 | 4,550 | 3.4 K to 4.6 K (+33.82 %) |
Jun 09 2017 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Option Exercise | A | 52.85 | 10,000 | 528,500 | 10,000 | |
Jun 09 2017 | AERI | AERIE PHARMACEUTIC ... | McHugh Julie | Director | Grant | A | 0.00 | 1,150 | 0 | 2,850 | 1.7 K to 2.9 K (+67.65 %) |
May 31 2017 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Sell | S | 55.95 | 10,182 | 569,683 | 1,950,477 | 2 M to 2 M (-0.52 %) |
May 31 2017 | AERI | AERIE PHARMACEUTIC ... | Foresite Capital Management II ... | 10% Owner | Sell | S | 55.95 | 9,818 | 549,317 | 1,672,714 | 1.7 M to 1.7 M (-0.58 %) |
May 17 2017 | AERI | AERIE PHARMACEUTIC ... | Cagle Gerald D. | Director | Buy | P | 39.90 | 1,000 | 39,900 | 12,900 | 11.9 K to 12.9 K (+8.40 %) |
Apr 20 2017 | AERI | AERIE PHARMACEUTIC ... | Cagle Gerald D. | Director | Buy | P | 41.80 | 1,000 | 41,800 | 11,900 | 10.9 K to 11.9 K (+9.17 %) |
Apr 20 2017 | AERI | AERIE PHARMACEUTIC ... | Cagle Gerald D. | Director | Buy | P | 41.60 | 1,000 | 41,600 | 10,900 | 9.9 K to 10.9 K (+10.10 %) |
Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Option Exercise | A | 44.25 | 43,019 | 1,903,591 | 43,019 | |
Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Payment of Exercise | F | 44.55 | 845 | 37,645 | 402,135 | 403 K to 402.1 K (-0.21 %) |
Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Payment of Exercise | F | 44.55 | 932 | 41,521 | 402,980 | 403.9 K to 403 K (-0.23 %) |
Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | RUBINO RICHARD J | Chief Financial Off ... | Grant | A | 0.00 | 4,780 | 0 | 403,912 | 399.1 K to 403.9 K (+1.20 %) |
Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Option Exercise | A | 44.25 | 79,418 | 3,514,247 | 79,418 | |
Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Payment of Exercise | F | 44.55 | 1,116 | 49,718 | 34,042 | 35.2 K to 34 K (-3.17 %) |
Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Payment of Exercise | F | 44.55 | 1,116 | 49,718 | 35,158 | 36.3 K to 35.2 K (-3.08 %) |
Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | MITRO THOMAS A | President and COO | Grant | A | 0.00 | 8,824 | 0 | 36,274 | 27.5 K to 36.3 K (+32.15 %) |
Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Option Exercise | A | 44.25 | 39,709 | 1,757,123 | 39,709 | |
Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Payment of Exercise | F | 44.55 | 593 | 26,418 | 185,061 | 185.7 K to 185.1 K (-0.32 %) |
Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Payment of Exercise | F | 44.55 | 741 | 33,012 | 185,654 | 186.4 K to 185.7 K (-0.40 %) |
Feb 27 2017 | AERI | AERIE PHARMACEUTIC ... | Kopczynski Casey C. | Chief Scientific Of ... | Grant | A | 0.00 | 4,412 | 0 | 186,395 | 182 K to 186.4 K (+2.42 %) |